Bovine Serum A lbum in, Gadolinium Complexes, Contrast A gents for NM R Imaging, Nitroxyls Bovine Serum A lbum in (BSA) was spin labeled using the active esters 3 and 5 containing a nitroxyl radical to give the spin labeled BSA derivatives 4 and 6. Spin labeled C D T A , D TPA and TTH A chelating agents 10, 13 and 16 and the corresponding BSA derivatives 17, 18 and 19 and their gadolinium complexes 20, 21 and 22 were synthesized. All these BSA derivatives were evaluated as possible contrast enhancing agents for NMR imaging by m easurem ent of spin-lattice (T,) and spin-spin (T2) relaxations and by calculations of relaxivities i.e., slopes of 1/T, versus concentration plots. The spin labeled BSA-complexon-gadolinium conjugates 20, 21 and 22 were found to have b etter relaxation times and relaxivities than the BSA spin labeled derivatives 4, 6, 17, 18 and 19. The spin count for the BSA derivatives 4, 6, 17, 18 and 19 and for their gadolinium conjugates 20, 21 and 22 was found to be between 9 -1 0 spins/molecule of the protein. The gadolinium conjugates 20, 21 and 22 of spin labeled BSA possess high relaxivities com bined with a nitroxyl m arker that could be used with E PR to assess pharm acokinetic behaviors of these potential contrast agents.
P aram agnetic com pounds, including nitroxyl rad i cals and m etal ion ch elates, have been recently evaluated as pharm aceuticals to enhance contrast on N M R im ages [1] [2] [3] [4] [5] , F or the m ost p art, com pounds have been selected for intravenous adm inistration th a t d istribute non-specifically in the vascular and extracellular fluid spaces and are renally excreted. T his non-specific p attern of distribution and ex cre tion has been found useful for contrast enhan cem en t on N M R im ages of kidneys, inflam m atory lesions, and breakdow n of the b lood-brain barrier [1, 2, 3, 6, 7] , T he d evelopm ent of one such m etallo-complex, g ad o lin iu m -D T P A , has advanced to the stage of clinical trials [6, 7] .
T o achieve m ore specific targeting of p ara m ag n e t ic contrast agents, attem p ts have been m ade to co n ju g ate m etallo-chelates to biom olecules including serum album in and m onoclonal antibodies [8] [9] [10] [11] . U nique featu res of serum album ins include (1) a biodistribution prim arily in the vascular space fol lowing intravenous adm inistration and (2) a re m a rk * Reprint requests to Prof. Dr. G. Sosnovsky.
V erlag d e r Z eitsch rift für N atu rfo rsch u n g , D-7400 T übingen 0 3 4 0 -5 0 8 7 /8 6 /0 9 0 0 -1 1 7 0 /$ 01.00/0 able ability to bind reversibly a w ide variety of o r ganic com pounds [12, 13] . T he p red o m in an t intravascular distribution of large m o lecu lar w eight biom olecules may be used to advantage for the p e r fu sio n -d ep en d en t N M R en h a n ce m e n t of organs such as the lungs and h ea rt [14] , A n ad d itio n al b en efit of these p aram ag n etic biom olecules is th a t th e co n ju g a tion to a large m olecular w eight species im proves the p ro to n relaxation en h an cem en t of th ese conjugates. The effect is a ttrib u ted to changes in co rrelatio n tim es [8] .
C ovalent m odification of serum album ins w ith n i troxyl spin labeling reag en ts have b een re p o rte d p re viously [15 -19] as p art of investigations o f pro tein co n form ational m obilities using E S R . T he m ultiple free am ino groups in serum album in are covalently linked w ith various nitroxyls, th e efficacy of th e in teractio n depending on b o th th e solubility o f the ni troxyl species in the aq u eo u s solution o f B S A and the pH . A lth o u g h several m eth o d s for th e activation of carboxyl groups in nitroxyl m olecules are available, such as, the use of acyl h alides, sym m etric or asym m etric anhydrides, and carbodiim ides [20] [21] [22] , use of active esters is p referab le because of relativ e ease of p rep a ra tio n , ch aracterizatio n and sto rag e, and ready solubility in aqu eo u s m edia. A d d itio n ally , the by-products of active esters in th eir conjugation w ith serum album ins are easily rem ovable. H en ce, in the p resent study tw o active esters 3 and 5 are em ployed to form bovine serum album in (B S A )-nitroxyl c o n ju gates.
A dditionally, p aram agnetic m etallo com plex co n jugates of BSA w ere synthesized as possibly su p e rio r alternatives for intravascular N M R contrast agents. T he use of com plexon m oieties, such as C D T A , D T P A , and T T H A resulting in chelates w ith large stability constants [23, 24] can eith er dim inish or elim inate the toxicity associated w ith m etal cations [25] , In the p resen t study, gadolinium *3 was chosen as the m ost suitable ion since it possesses a high m agnetic m o m en t, seven un p aired electrons, a re la tively long electronic relaxation tim e, and a labile hydration sphere.
In anticipation of strong p ro to n relaxation effects, conjugation of BSA with the gadolinium chelates containing polyam ino carboxylate functions, includ ing C D T A (7), D T P A (11) and T T H A (14) are now explored. F u rth e rm o re , the incorp o ratio n of the nitroxyl m oiety into such chelates p rio r to conjugation w ith BSA , and the interaction of the resulting spin labeled BSA com plexons 17, 18 and 19 with gadolinium to give spin labeled BSA com plexonm etal ion conjugates 20, 21 and 22, respectively, could provide useful probes for the E SR analysis of pharm acokinetics.
R ecently, we rep o rted the spin labeled chelating agents and th e ir gadolinium com plexes as possible contrast enhancers in N M R im aging [26] , W e now rep o rt the synthesis and p ro to n relaxation effective ness of spin labeled BSA 4 and 6 , spin labeled BSA com plexons 17, 18 and 19, and th e ir gadolinium co m plexes 20, 21 and 22 as agents w ith po ten tial ap p lica tions for in vivo N M R contrast en h an cem en t.
R esults and D iscussion
The transfer reag en t 3 was p re p a re d in 90% yield by reacting 1 and 2 in the presence of dicyclohexylcarbodiim ide (D C C ) in accordance w ith the Schem e I. (Schem e II), the substitution on the pro tein was achieved 1) w ithout the use of organic solvents and 2) w ith a b etter control over the n u m b er of su b stitu en ts per protein m olecule than th at o b tain ed w ith w ater insoluble active esters [20] [21] [22] . F u rth e r, th e use of w ater soluble active esters sim plifies the purifications process since all reaction by-products, such as, the l-hydroxy-2-nitrobenzene-4-sulfonic acid (by using 3) or N -hydroxysuccinim ide (by using 5), and the u nreacted excess of the tran sfer reagents 3 and 5, and the nitroxyl carboxylates are w ater so lu ble an d , h ence, w ere readily rem oved by exhaustive dialysis against a 0.1 N am m onium hydroxide so lu tion. L yophilization of th e dialysate yielded th e n i troxyl spin labeled pro tein s 4 and 6 as dry pow ders. T he dianhydrides 8 and 12 w ere p rep a re d acco rd ing to the literatu re m eth o d [5] . D ian h y d rid e 15 was analogously p rep ared by an ad ap tatio n of the lite ra tu re p ro ced u re [5] (Schem e III). T hese dianhydrides w ere reacted [26, 28] am ino fu n ctio n alities and the carboxylate m oiety of th e nitroxyl radical. T he spin lab eled BSA com plexons w ere th en co n ju g a ted w ith th e gadolinium ion by th e m ethods analogous to th a t re p o rte d in the literatu re [20, 29] .
T hus, co m p o u n d s 17, 18 and 19 w ere reacted with 0 0 8 10 a The concentration of each sample was 100 «M. Each sam ple, except 6 , was dissolved in deionized w ater. Compound 6 was dissolved in a 250 mM olar am monium bicarbonate solution; b E PR spectra were obtained using 100 ^M olar solu tions; c relaxation times T, and T 2 were m easured at 24 °C. For deionized w ater T, = 2150 m sec, T2 = 182 m sec; d slopes of 1/T, versus concentration plots (50-2 0 0 /<M); e in clinical tests Refs. [6 , 7] ; 1 see Ref. [35] , Table I . Spin-lattice (T,) and spinspin (T2) relaxation times and the relaxivities of spin labeled BSA and their gadolinium complexes". In conclusion, the spin labeled B SA -com plexongadolinium conjugates 20, 21 and 22 contain gadolinium , which is a very efficient relaxation e n hancer, and a nitroxyl m ark er w hich could be useful in m onitoring pharm acokinetics by E S R in biological system s [31] . H en ce, com pounds 20, 21 and 22 ap p ea r to have su p erio r relaxation characteristics as p o ten tial N M R co n trast enhancing agents. A dditional tests of stabilities, toxicities, pharm acokinetics and in vivo effectiveness will serve to optim ize the choice of a can d id ate com pound for fu rth er developm ent.
E x p erim en tal

M aterials and m ethods
A ll chem icals w ere of the finest quality available com m ercially. B ovine Serum A lbum in (BSA ) was p u rch ased from Sigm a Chem ical Co. Solvents w ere d ried using stan d ard procedures [32] , A u thentic sam ples of sodium 4-hydroxy-3-nitrobenzene sulfonate [33] 
A n a lytica l procedures
All m elting points w ere o b tain ed w ith a T hom as-H o o v er capillary m elting point ap p aratu s using a cali b rate d th e rm o m ete r and are uncorrected. F o r purity control T L C p reco ated sheets, silica gel 60 F254 w ere used. T he m icroanalyses were p erfo rm ed on a Perkin-E lm e r 240 C E lem en tal A nalyzer. IR Spectra w ere reco rd ed on a N icolet MX-1 F T /IR S p ectro p h o to m eter. M ass sp ectra were o b tained on a H ew lett-P ackard mass sp ectro m eter, m odel 5985 GS, using a direct insertion p ro b e, a source pressure of 2 x 10"7 to rr, and eith er m ethane as a reactant gas for chem ical ionization or electron im pact. T h erefo re, e ith er the M + + l or M~ values are rep o rted . T he E P R spectra of eith er 10"4 M aqueous solutions of the nitroxyl radicals or 100 ^M aqueous solutions of the BSA spin labels were recorded in a capillary on a V arian E-115 E P R Spectrom eter. T he spin count of th e BSA spin labels was calculated [30] using the do uble integrals of the first derivatives of the E P R sp ectra of the corresponding BSA spin labels.
T he relaxation tim es (Table I ) of 1 0 0 /^M so lu tions of the BSA spin labels w ere m easured at 24 °C using satu ratio n recovery for T] and spin echo for T 2 m ethods on a Praxis pulsed N M R analy zer m odel PR-103, 10.7 M H z, 0.251 T esla, th e Praxis C orp. San A n to n io , T exas, U SA . T he relaxivities (T able I) of these BSA spin labels w ere calculated from the slopes of the plots of 1/Tt v er sus co n cen tratio n s ( 5 0 -2 0 0 //M ). T he values of the slopes w ere co m p u ted using least square m ethods. 
Preparation o f sodium 4-(2' ,2' ,5' ,5 '-tetramethyl-1 '-o xyl-3 ' -pyrroline-3'-carbonyloxy) -3-n itrobenzenesulfonate
Spin labeling o f B ovine Serum A lb u m in (B S A ) using spin labeled transfer reagents 3 and 5. Preparation o f 4 and 6
Bovine S erum A lbum in (250 mg, 4 ^m ol) was dis solved o v er a period of 10-15 m in in a 0.1 N sodium b ic arb o n ate solution (7.5 m l) and to this solution was ad d ed e ith e r the active ester 3 (204 mg, 0.5 m m ol) or th e active este r 5 (141 mg, 0.5 m m ol). The reaction m ixture was diluted to 30-40 ml using deionized w a te r. T h e p H of the solution was adjusted to 8.5 w ith a 0.1 N sodium hydroxide solution. The solution con taining th e active ester 5 was stirred at am bient te m p e ra tu re fo r 24 h for com plete dissolution of the ac tive ester 5. T he solution was kept in a refrigerator at 4 °C fo r 24 h adjusting the p H to 8.5 with a 0.1 N sodium hydroxide solution (2 -5 m l). The solution w as th e n exhaustively dialyzed in a 0.1 N am m onium hydroxide solution (1000 ml) for 24 h. The eluant was rep laced w ith a freshly p rep ared 0.1 N am m onium hydroxide solution (1000 ml) every 4 h. T he eluant was p eriodically checked for the presence of free nitroxyl radicals by E S R spectroscopy. A fter 24 h the elu an t co n tain ed no free nitroxyl radicals. A fter the dialysis th e solution was lyophilized to give 190 mg of th e yellow colored spin labeled BSA derivative 4 using th e active ester 3, and 190 mg of the w hite colo red spin labeled B SA derivative 6 using the ac tive este r 5.
Preparation o f 8, 12 and triethylenetetraam inehexaacetic acid dianhydride 15
T he dian h y d rid es 8 and 12 w ere p rep ared accord ing to th e literatu re m eth o d [26] . C om p o u n d 15 was analogously p re p a re d by an ad ap tatio n o f th e litera tu re p ro ced u re [26] .
A m ixture of 14 (1.731 g, 3.5 m m ol), acetic anhy dride (3 m l) and pyridine (2 ml) was stirred at 45 -48 °C for 2 h, and at 24 °C for 6 h. 
